Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers
Event Calendar

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Event Calendar
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
News|Articles|May 18, 2016

Best Practices for Product Transfer

Author(s)Sponsor's Content
Advertisement

Advertisement
Manufacturing
|
Intellectual Property and Patents

Related Content

Advertisement
How China's biotech surge is reshaping US drug licensing, manufacturing control, and FDA data trust, the key shifts pharma professionals must track.

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

ByZachary Zubulake,Saharsh Davuluri,John Stanford
August 18th 2026
Green gelatin capsule resting on a translucent amber liquid drop, isolated on transparent background | Image Credit: ©Nina -stock.adobe.com

A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations

ByUsha Chowdhury ,Jyothi Gautam,Erin Burke
August 17th 2026
Glenn Herring, Technical Operations Consultant, Halo

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands

ByGlenn Herring,Zachary Zubulake
August 17th 2026

CPHI Milan Puts Sustainability to Work, Part 2

BySilvia Forroova
August 14th 2026

PharmTech Weekly Roundup—August 14, 2026

BySusan Haigney
August 14th 2026
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

2

A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations

3

Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands

4

Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing

5

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us